Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
Intervention1: intracervical lignocaine injection: 1 percent lignocaine injection will be given intracervically
Intervention2: 10 percent lignocaine spray: 4 puffs of 10 percent lignocaine spray will
Sponsors
pgimer
Eligibility
Inclusion criteria
Inclusion criteria: women undergoing office endometrial biopsy for various indications
Exclusion criteria
Exclusion criteria: pregnant women ,uterus size more than 12 week, known hypersensitivity to lignocaine and NSAIDs ,pid, any previous surgery on cervix,medical disorders like bronchial asthma, cardiovascular disorders , uncontrolled hypertension or diabetes ,moderate or severe anaemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| severity of pain perceived by the women during office endometrial biopsyTimepoint: severity of pain perceived by the women during office endometrial biopsy and 15-30 minutes post procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| adequacy of sampleTimepoint: histopathology report will be collected 2 weeks post procedure;complications during the procedureTimepoint: measuring bp and PR before and after the procedure;ease of insertion of Karman cannulaTimepoint: will be rated as easy and difficult | — |
Countries
India
Contacts
Public ContactDr Surbhi Sharma
Post graduate institute of medical education and research
Outcome results
None listed